Lit Matters #3: Anticoagulating SSPEs and Recurrent VTE Risk

Subsegmental pulmonary embolism is often overcalled on CTPA, and isolated SSPE without proximal DVT carries a low but real short-term risk of recurrent VTE. The key clinical question is not whether every SSPE gets anticoagulated, but which low-risk patients may be observed with structured follow-up and shared decision-making.

Subsegmental PE Without Anticoagulation

• False positive signal: Isolated subsegmental PE on CTPA is less reliable than larger clot burden, with retrospective radiology review calling many solitary SSPEs false positives or even negative on reread.
• Guideline supported surveillance: CHEST guidelines allow clinical surveillance over anticoagulation in selected SSPE patients when there is no lower-extremity DVT and recurrence risk appears low.
• Ninety day recurrence risk: In this prospective cohort, untreated isolated SSPE had a 3.1% cumulative recurrent VTE risk at 90 days, reinforcing that the hazard is low but not zero.
• Single versus multiple defects: Clot burden mattered: single SSPE had about 2.1% recurrence, while multiple isolated SSPEs were closer to 5.7%, a distinction worth hearing in the episode.
• Screening for occult DVT: Patients underwent bilateral leg ultrasound before withholding anticoagulation, underscoring that observation is tied to actively excluding proximal DVT rather than simply discharging.
• Shared decision framing: There were no PE deaths in follow-up, but recurrence still occurred, so the practical takeaway is shared decision-making that balances recurrent clot risk against anticoagulant bleeding harm.